SEC61G and lung adenocarcinoma: To further investigate the prognostic value of SEC61G expression in lung adenocarcinoma (LUAD), we analyzed two independent cohorts: the TCGA-LUAD dataset (n = 535) and a LUAD tissue microarray cohort (n = 79).